Forte Biosciences, Inc. (FBRX)

Forte Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22	30	21	32	467	13
Market Cap Growth	19.42%	42.17%	-33.49%	-93.24%	3566.23%	-92.22%
Enterprise Value	-9	-7	-20	-10	408	6
PE Ratio	-	-0.95	-1.51	-1.45	-10.05	-3.13
PB Ratio	0.75	0.85	0.54	0.76	7.92	-2.67
P/FCF Ratio	-0.84	-1.04	-2.57	-1.89	-25.36	-4.34
P/OCF Ratio	-0.84	-1.04	-2.57	-1.89	-25.36	-4.60
EV/EBITDA Ratio	0.16	0.23	1.45	0.48	-8.80	-1.43
EV/EBIT Ratio	0.16	0.23	1.45	0.48	-8.79	-1.43
EV/FCF Ratio	0.17	0.25	2.46	0.63	-22.17	-1.98
Quick Ratio	9.14	10.13	12.93	23.92	26.01	3.63
Current Ratio	9.45	10.46	13.06	24.19	26.52	3.93
Return on Equity (ROE)	-99.40%	-94.30%	-34.70%	-45.70%	-175.00%	-16.90%
Return on Assets (ROA)	-85.70%	-81.40%	-33.00%	-43.30%	-142.00%	-6.30%
Return on Capital (ROIC)	-116.56%	-91.99%	-35.80%	-51.71%	-78.47%	85.22%
Earnings Yield	-149.50%	-105.42%	-66.09%	-68.75%	-9.95%	-31.93%
FCF Yield	-140.75%	-96.44%	-38.98%	-52.82%	-3.94%	-23.02%
Buyback Yield / Dilution	-119.37%	-81.61%	-24.45%	-89.81%	-249.05%	-57.65%
Total Shareholder Return	-119.37%	-81.61%	-24.45%	-89.81%	-249.05%	-57.65%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).